Evogene Ltd. Files 20-F, Details 2024 Financials & Stock Split
Ticker: EVGN · Form: 20-F · Filed: Mar 27, 2025 · CIK: 1574565
Sentiment: neutral
Topics: 20-F, annual-report, stock-split, financials
TL;DR
Evogene 20-F filed: 2024 financials out, 1:10 reverse stock split effective July 25, 2024.
AI Summary
Evogene Ltd. filed its 20-F annual report for the fiscal year ending December 31, 2024. The company, incorporated in L3 and headquartered in Rehovot, Israel, operates in the agriculture chemicals sector. The filing details financial adjustments, including a 1:10 reverse stock split effective July 25, 2024, which retroactively adjusted share counts and par value. Specific grant amounts from EU Horizon were also noted.
Why It Matters
This filing provides investors with a comprehensive overview of Evogene's financial performance and significant corporate actions like the recent stock split, crucial for understanding the company's current standing and future outlook.
Risk Assessment
Risk Level: medium — The filing indicates potential anti-dilutive effects from options and RSUs, and retroactive adjustments to share data, suggesting complexity in financial reporting and share structure.
Key Numbers
- 1:10 — Reverse Stock Split Ratio (Effective July 25, 2024, impacting share counts and par value.)
- 2024 — Fiscal Year End (The period covered by the 20-F filing.)
Key Players & Entities
- Evogene Ltd. (company) — Filer of the 20-F report
- 2024-12-31 (date) — Fiscal year end
- 2025-03-27 (date) — Filing date
- 1:10 (dollar_amount) — Ratio of reverse stock split
- July 25, 2024 (date) — Effective date of reverse stock split
- EU Horizon (company) — Source of grants
FAQ
What is the primary business of Evogene Ltd. as indicated in the filing?
Evogene Ltd. is primarily involved in AGRICULTURE CHEMICALS, with a Standard Industrial Classification code of [2870].
When was the reverse stock split effective and what was its ratio?
The reverse stock split was effective on July 25, 2024, at a ratio of 1-for-10.
What impact did the reverse stock split have on the company's share data?
The reverse stock split retroactively adjusted the number of shares and par value, and also affected the weighted number of shares for prior years.
Are there any specific grants mentioned in the filing?
Yes, EU Horizon grant amounts received in May 2023 and August 2024 are excluded from certain reported figures.
What is the business address of Evogene Ltd.?
The business address is 13 Gad Feinstein Street, Park Rehovot, Rehovot, L3, 7638517.
Filing Details
This Form 20-F (Form 20-F) was filed with the SEC on March 27, 2025 regarding Evogene Ltd. (EVGN).